126 related articles for article (PubMed ID: 16245689)
1. [Theoretical conformational analysis in the determination of productive conformations of substrates for acetylcholinesterase and butyrylcholinesterase].
Belinskaia DA; Shestakova NN
Bioorg Khim; 2005; 31(5):466-73. PubMed ID: 16245689
[TBL] [Abstract][Full Text] [Related]
2. [Determination of productive conformations of acetylcholinesterase substrates using theoretical conformational analysis].
Shestakova NN; Rozengart EV; Khovanskikh AE; Zhorov BS; Govyrin VA
Bioorg Khim; 1989 Mar; 15(3):335-44. PubMed ID: 2742614
[TBL] [Abstract][Full Text] [Related]
3. Modeling effects of oxyanion hole on the ester hydrolysis catalyzed by human cholinesterases.
Gao D; Zhan CG
J Phys Chem B; 2005 Dec; 109(48):23070-6. PubMed ID: 16854005
[TBL] [Abstract][Full Text] [Related]
4. Reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of acetylcholine.
Chen X; Fang L; Liu J; Zhan CG
J Phys Chem B; 2011 Feb; 115(5):1315-22. PubMed ID: 21175195
[TBL] [Abstract][Full Text] [Related]
5. Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.
Fang L; Pan Y; Muzyka JL; Zhan CG
J Phys Chem B; 2011 Jul; 115(27):8797-805. PubMed ID: 21682268
[TBL] [Abstract][Full Text] [Related]
6. Productive substrate sorption in acetylcholinesterase and butyrylcholinesterase active sites according to theoretical conformational analysis.
Belinskaya DA; Shestakova NN
Dokl Biochem Biophys; 2004; 396():146-50. PubMed ID: 15378912
[No Abstract] [Full Text] [Related]
7. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
[TBL] [Abstract][Full Text] [Related]
8. An inhibitor-free assay of acetylcholinesterase and butyrylcholinesterase in the cerebrospinal fluid.
Kluge HH; Kluge WH; Hartmann W
Clin Chim Acta; 1999 Apr; 282(1-2):135-45. PubMed ID: 10340441
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.
Nicolet Y; Lockridge O; Masson P; Fontecilla-Camps JC; Nachon F
J Biol Chem; 2003 Oct; 278(42):41141-7. PubMed ID: 12869558
[TBL] [Abstract][Full Text] [Related]
10. [Conformational differences in the sorption of choline ligands at the active site of acetylcholinesterase].
Shestakova NN; Rozengart EV
Bioorg Khim; 1995 May; 21(5):323-9. PubMed ID: 7661856
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
12. Time-course of human cholinesterases-catalyzed competing substrate kinetics.
Mukhametgalieva AR; Aglyamova AR; Lushchekina SV; Goličnik M; Masson P
Chem Biol Interact; 2019 Sep; 310():108702. PubMed ID: 31247192
[TBL] [Abstract][Full Text] [Related]
13. Hysteresis of butyrylcholinesterase in the approach to steady-state kinetics.
Masson P; Schopfer LM; Froment MT; Debouzy JC; Nachon F; Gillon E; Lockridge O; Hrabovska A; Goldstein BN
Chem Biol Interact; 2005 Dec; 157-158():143-52. PubMed ID: 16256969
[TBL] [Abstract][Full Text] [Related]
14. [Boundaries of the butyrylcholinesterase anion site from data of a conformational analysis of substrates].
Rozengart EV; Zhorov BS
Zh Evol Biokhim Fiziol; 1989; 25(2):189-94. PubMed ID: 2750365
[TBL] [Abstract][Full Text] [Related]
15. Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
Chiou SY; Huang CF; Hwang MT; Lin G
J Biochem Mol Toxicol; 2009; 23(5):303-8. PubMed ID: 19827033
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
17. Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS.
Liu W; Yang Y; Cheng X; Gong C; Li S; He D; Yang L; Wang Z; Wang C
J Pharm Biomed Anal; 2014 Jun; 94():215-20. PubMed ID: 24631841
[TBL] [Abstract][Full Text] [Related]
18. Excavations into the active-site gorge of cholinesterases.
Soreq H; Gnatt A; Loewenstein Y; Neville LF
Trends Biochem Sci; 1992 Sep; 17(9):353-8. PubMed ID: 1412713
[TBL] [Abstract][Full Text] [Related]
19. Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity.
Hartmann J; Kiewert C; Duysen EG; Lockridge O; Greig NH; Klein J
J Neurochem; 2007 Mar; 100(5):1421-9. PubMed ID: 17212694
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
